BioSpace News Archive

fter 100 days of action, DHHS Secretary Alex M. Azar released a report on the early results of the American Patient First Blueprint. The report reiterates the Administration’s call for greater competition in the pharmaceutical marketplace to address rising drug prices and reduce out-of-pocket costs.

5-year Growth Includes a New, Yet Historic Corporate Home and a Renewed Passion for Ending Preventable Blindness

Ocular Therapeutix, Inc. today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018 at 11:30 AM ET at the Intercontinental Barclay Hotel in New York, NY.

Selexis SUREtechnology Platform™ Successfully Expresses Hoba’s HB-086 in CHO Cells

Tarveda Therapeutics, Inc., announced that Drew Fromkin, President and Chief Executive Officer, will present at the Cantor Fitzgerald 2018 Global Healthcare Conference, occurring October 1-3, 2018 in New York City.

Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that President and CEO Jayson Dallas, M.D., will participate in a fireside chat at the Cantor Global Healthcare Conference in New York on Wednesday, October 3, 2018, at 10:55 a.m. Eastern Time.

Decibel to Unify Data and Scale with Medidata Cloud

SENTIO MMG Platform uses differentiated technology to identify nerve status in MIS and Open Spine Surgery providing reliable real-time feedback designed to support surgical decision making and potential efficiency during surgery

New solution integrates PatientKeeper Charge Capture into ShareableFORMS’s native iPad app for clinical documentation to streamline physician workflow at the point of care

3D Systems (NYSE: DDD), the originator of 3D printing, has been selected as a 2018 recipient of the Cellerant Best of Class Technology Award for its NextDentTM 5100.